Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract

P. Antonio Maldonado, T. Ignacio Montoya, Jesus F. Acevedo, Patrick W. Keller, R. Ann Word

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Although the positive effects of vaginal estrogens and the selective estrogen receptor modulator, ospemifene (OS), on the vaginal epithelium are well recognized, less is known regarding the effects of these therapies on the lower urinary tract or vaginal muscularis. Clinical evidence suggests that vaginally administered estrogenmay improve overactive bladder-related symptoms. The objective of this study was to compare the effects of OS, vaginal conjugated equine estrogens (CEE), or both on the vaginal wall and lower urinary tract in a rat model of menopause. Contractile force of the bladder neck, dome, and external urethral sphincter at optimal field stimulation did not differ significantly among treatment groups. Pharmacologic responses to atropine, carbachol, and potassium chloride were similar among groups. Vaginal epithelial thickness and differentiation were differentially regulated by CEE or OS. Ospemifene altered epithelial differentiation pathways in vaginal epithelium in a unique way, and these effects were additive with local CEE. Unless contraindicated, the beneficial effects of vaginal CEE on the vaginal wall outweigh those of OS.

Original languageEnglish (US)
Article number143461
Pages (from-to)81-92
Number of pages12
JournalBiology of Reproduction
Volume96
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Conjugated (USP) Estrogens
Urinary Tract
Epithelium
Selective Estrogen Receptor Modulators
Overactive Urinary Bladder
Potassium Chloride
Carbachol
Urethra
Menopause
Atropine
Estrogens
Urinary Bladder
Ospemifene

Keywords

  • Bladder
  • Estrogen
  • Menopause
  • Premarin
  • SERMs
  • Urethra
  • Vagina
  • Vulvovaginal atrophy

ASJC Scopus subject areas

  • Cell Biology

Cite this

Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract. / Maldonado, P. Antonio; Montoya, T. Ignacio; Acevedo, Jesus F.; Keller, Patrick W.; Word, R. Ann.

In: Biology of Reproduction, Vol. 96, No. 1, 143461, 01.01.2017, p. 81-92.

Research output: Contribution to journalArticle

Maldonado, P. Antonio ; Montoya, T. Ignacio ; Acevedo, Jesus F. ; Keller, Patrick W. ; Word, R. Ann. / Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract. In: Biology of Reproduction. 2017 ; Vol. 96, No. 1. pp. 81-92.
@article{935c5395873f4a9993041157a7e4a3be,
title = "Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract",
abstract = "Although the positive effects of vaginal estrogens and the selective estrogen receptor modulator, ospemifene (OS), on the vaginal epithelium are well recognized, less is known regarding the effects of these therapies on the lower urinary tract or vaginal muscularis. Clinical evidence suggests that vaginally administered estrogenmay improve overactive bladder-related symptoms. The objective of this study was to compare the effects of OS, vaginal conjugated equine estrogens (CEE), or both on the vaginal wall and lower urinary tract in a rat model of menopause. Contractile force of the bladder neck, dome, and external urethral sphincter at optimal field stimulation did not differ significantly among treatment groups. Pharmacologic responses to atropine, carbachol, and potassium chloride were similar among groups. Vaginal epithelial thickness and differentiation were differentially regulated by CEE or OS. Ospemifene altered epithelial differentiation pathways in vaginal epithelium in a unique way, and these effects were additive with local CEE. Unless contraindicated, the beneficial effects of vaginal CEE on the vaginal wall outweigh those of OS.",
keywords = "Bladder, Estrogen, Menopause, Premarin, SERMs, Urethra, Vagina, Vulvovaginal atrophy",
author = "Maldonado, {P. Antonio} and Montoya, {T. Ignacio} and Acevedo, {Jesus F.} and Keller, {Patrick W.} and Word, {R. Ann}",
year = "2017",
month = "1",
day = "1",
doi = "10.1095/biolreprod.116.144428",
language = "English (US)",
volume = "96",
pages = "81--92",
journal = "Biology of Reproduction",
issn = "0006-3363",
publisher = "Society for the Study of Reproduction",
number = "1",

}

TY - JOUR

T1 - Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract

AU - Maldonado, P. Antonio

AU - Montoya, T. Ignacio

AU - Acevedo, Jesus F.

AU - Keller, Patrick W.

AU - Word, R. Ann

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Although the positive effects of vaginal estrogens and the selective estrogen receptor modulator, ospemifene (OS), on the vaginal epithelium are well recognized, less is known regarding the effects of these therapies on the lower urinary tract or vaginal muscularis. Clinical evidence suggests that vaginally administered estrogenmay improve overactive bladder-related symptoms. The objective of this study was to compare the effects of OS, vaginal conjugated equine estrogens (CEE), or both on the vaginal wall and lower urinary tract in a rat model of menopause. Contractile force of the bladder neck, dome, and external urethral sphincter at optimal field stimulation did not differ significantly among treatment groups. Pharmacologic responses to atropine, carbachol, and potassium chloride were similar among groups. Vaginal epithelial thickness and differentiation were differentially regulated by CEE or OS. Ospemifene altered epithelial differentiation pathways in vaginal epithelium in a unique way, and these effects were additive with local CEE. Unless contraindicated, the beneficial effects of vaginal CEE on the vaginal wall outweigh those of OS.

AB - Although the positive effects of vaginal estrogens and the selective estrogen receptor modulator, ospemifene (OS), on the vaginal epithelium are well recognized, less is known regarding the effects of these therapies on the lower urinary tract or vaginal muscularis. Clinical evidence suggests that vaginally administered estrogenmay improve overactive bladder-related symptoms. The objective of this study was to compare the effects of OS, vaginal conjugated equine estrogens (CEE), or both on the vaginal wall and lower urinary tract in a rat model of menopause. Contractile force of the bladder neck, dome, and external urethral sphincter at optimal field stimulation did not differ significantly among treatment groups. Pharmacologic responses to atropine, carbachol, and potassium chloride were similar among groups. Vaginal epithelial thickness and differentiation were differentially regulated by CEE or OS. Ospemifene altered epithelial differentiation pathways in vaginal epithelium in a unique way, and these effects were additive with local CEE. Unless contraindicated, the beneficial effects of vaginal CEE on the vaginal wall outweigh those of OS.

KW - Bladder

KW - Estrogen

KW - Menopause

KW - Premarin

KW - SERMs

KW - Urethra

KW - Vagina

KW - Vulvovaginal atrophy

UR - http://www.scopus.com/inward/record.url?scp=85022339260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022339260&partnerID=8YFLogxK

U2 - 10.1095/biolreprod.116.144428

DO - 10.1095/biolreprod.116.144428

M3 - Article

VL - 96

SP - 81

EP - 92

JO - Biology of Reproduction

JF - Biology of Reproduction

SN - 0006-3363

IS - 1

M1 - 143461

ER -